Top Markets
#1 ADO Protocol ADO Protocol +334.60%
#2 Islamic Coin Islamic Coin +155.41%
#3 GoPlus Security GoPlus Security +38.11%
#4 Starpower Starpower +35.19%
#5 GAIB AID GAIB AID +24.67%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.81%
#7 Casper Network Casper Network +14.74%
#8 Power Protocol Power Protocol +11.88%
#9 Nockchain Nockchain +11.57%
#10 o1.exchange o1.exchange +11.28%
Coin of the day
ADO Protocol ADO Protocol
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Eagle Pharmaceuticals, Inc. Eagle Pharmaceuticals, Inc.

Eagle Pharmaceuticals, Inc.

EGRX
Classement en actions #33346
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on... Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on manufacturing, developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company’s product portfolio offers RYANODEX for malignant hyperthermia; and BELRAPZO and BENDEKA for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin’s lymphoma. It also produces PEMFEXY, a ready-to-dilute liquid form of pemetrexed injection, indicated in combination with cisplatin for the initial treatment of patients with malignant pleural mesothelioma and non-small cell lung cancer; BARHEMSYS, a selective dopamine-2 (D2) and dopamine-3 (D3) receptor antagonist indicated in adults for prevention of postoperative nausea and vomiting (PONV); BYFAVO, a benzodiazepine indicated for the induction and maintenance of procedural sedation in adults. The company has license and collaboration agreements with Combioxin, SA for the development and commercialization rights to CAL02, an anti-toxin agent in Phase 2 development for the treatment of severe pneumonia in combination with traditional antibacterial drugs; ENA-001 developed by Enalare, an agnostic respiratory stimulant for respiratory depression; EA-114, novel and proprietary formulation of fulvestrant developed for hormone-receptor-positive (HR+) metastatic breast cancer. It has a strategic collaboration with Tyme Technologies, Inc. for the development of SM-88 to treat cancer. Eagle Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Woodcliff Lake, New Jersey.
Prix de l'action
$0.595
Dernière synchronisation: 2026-08-13
Capitalisation boursière
$7.83M
Changement (1 jour)
0.00%
Changement (1 an)
-81.41%
Pays
US
Échange Eagle Pharmaceuticals, Inc. (EGRX)

Catégorie

Healthcare
Historique du prix de l'action pour Eagle Pharmaceuticals, Inc. (EGRX)
Prix de clôture le plus élevé : $0.27 le 2026-08-01

Prix de clôture le plus bas : $12.89 le 2014-02-01
Historique du prix de l'action de Eagle Pharmaceuticals, Inc. de 2014 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 96.79%
2025 -29.61%
2024 -87.52%
2023 -82.65%
2022 -38.74%
2021 7.84%
2020 -20.71%
2019 39.37%
2018 -25.22%
2017 -26.15%
2016 -16.70%
2015 591.76%
2014 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 $171.67 -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 $161.26 22.94%
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 $35.97 20.03%
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 $222.59 36.04%
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $20.77 10.96%
IN